| Parameter | Specification | Source |
|---|---|---|
| Expression Host | E. coli | |
| Tag Type | N-terminal His-tag | |
| Protein Form | Lyophilized powder | |
| Storage Buffer | Tris-based buffer with 50% glycerol (pH 8.0) |
Reconstitution: Dissolve in deionized water (0.1–1.0 mg/mL), with optional 5–50% glycerol for long-term storage .
Vaccine development: As a target antigen for anthrax research .
Antibody production: His-tag facilitates affinity purification for immunological studies .
Structural biology: Full-length sequence enables crystallography or cryo-EM studies .
Functional data: No explicit pathways or interacting proteins are documented in available literature .
Therapeutic context: No clinical trials or efficacy studies reported .
| Condition | Recommendation | Source |
|---|---|---|
| Short-term | 4°C (up to 1 week) | |
| Long-term | -20°C/-80°C with 50% glycerol | |
| Freeze-thaw cycles | Avoid; aliquot before storage |
Functional characterization: Elucidating its role in B. anthracis pathogenesis.
Interaction mapping: Identifying binding partners using yeast two-hybrid assays.
Therapeutic targeting: Assessing immunogenicity for vaccine development.
KEGG: ban:BA_0538
STRING: 260799.BAS0506
For optimal preservation of recombinant UPF0295 protein BA_0538 activity:
Storage recommendations:
Store lyophilized powder at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use
Avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (recommended default: 50%)
Aliquot for long-term storage at -20°C/-80°C
The protein is typically supplied in a Tris/PBS-based buffer with 6% Trehalose at pH 8.0, which helps maintain stability during storage .
Recombinant UPF0295 protein BA_0538/GBAA_0538/BAS0506 is typically expressed in E. coli expression systems with an N-terminal His-tag to facilitate purification. The production workflow follows these general steps:
Cloning of the BA_0538 gene (encoding amino acids 1-118) into an expression vector with an N-terminal His-tag
Transformation into competent E. coli cells
Induction of protein expression under optimized conditions
Cell lysis and extraction of total protein
Affinity purification using His-tag binding resins
Quality control assessment:
SDS-PAGE for purity verification (typically >90%)
Western blot for specificity confirmation
Mass spectrometry for identity confirmation
Lyophilization for stable storage
The final product is typically validated to have a purity greater than 90% as determined by SDS-PAGE analysis .
When designing experiments to characterize proteins of unknown function like UPF0295, a systematic approach incorporating multiple experimental designs is recommended:
Recommended experimental design hierarchy:
| Design Type | Experimental Approach | Advantages |
|---|---|---|
| A. Single-group designs | One-group pretest-posttest with double pretest | Helps refute regression to the mean effects |
| B. Control group designs without pretest | Posttest-only design with nonequivalent groups | Controls for external factors |
| C. Control group designs with pretest | Untreated control with dependent samples | Assesses initial comparability of groups |
| D. Time-series designs | Multiple measurements before and after intervention | Robust against temporal confounders |
For UPF0295 protein specifically, consider implementing:
Comparative interactome analysis: Using techniques like co-immunoprecipitation followed by mass spectrometry to identify protein binding partners
Gene knockout/knockdown studies: Assess phenotypic changes in Bacillus anthracis when BA_0538 is deleted or suppressed
Localization studies: Determine subcellular localization using fluorescent tagging or immunocytochemistry
Structural analysis: Apply X-ray crystallography or cryo-EM to determine three-dimensional structure
Implement the experimental control design notation from the established hierarchy to ensure replicability and validity of findings .
Antibody validation is critical for accurate UPF0295 protein detection. A comprehensive validation protocol should include:
Western blot analysis:
Compare recombinant UPF0295 protein as positive control
Include knockout/knockdown samples as negative controls
Verify expected molecular weight (approximately 13 kDa plus tag size)
Cross-reactivity assessment:
Test against closely related UPF0295 family proteins from other species
Examine reactivity with homologs like Geobacillus thermodenitrificans UPF0295 (GTNG_0491)
Immunoprecipitation efficiency:
Quantify protein recovery percentages
Verify specificity using mass spectrometry
Epitope mapping:
Identify specific binding regions within BA_0538 sequence
Avoid antibodies targeting highly conserved regions if specificity is required
These validation steps are essential as poor antibody specificity has been identified as a major contributor to irreproducibility in biological research. Following standardized antibody validation protocols significantly improves experimental reliability and reproducibility .
When investigating UPF0295 protein in complex biological systems where randomization may not be feasible, several quasi-experimental designs offer robust alternatives:
Recommended quasi-experimental designs:
| Design Category | Specific Design | Notation | Application for UPF0295 |
|---|---|---|---|
| Time-series designs | Interrupted time-series | O₁ O₂ O₃ X O₄ O₅ O₆ | Track UPF0295 expression patterns before and after stimuli |
| Removed treatment designs | ABA design | O₁ X O₂ remove-X O₃ | Test reversibility of UPF0295-mediated effects |
| Nonequivalent control designs | Switching replications | Group 1: O₁ X O₂ O₃ Group 2: O₁ O₂ X O₃ | Compare UPF0295 effects across different cell populations |
When implementing these designs, researchers should:
Define clear operational measurements (O)
Precisely characterize interventions (X)
Document any temporal trends in UPF0295 expression or activity
Account for potential confounding variables
Include appropriate statistical controls for regression to the mean
To strengthen validity, researchers should acknowledge design limitations explicitly and consider combining multiple quasi-experimental approaches to triangulate findings .
Comparative analysis between UPF0295 protein BA_0538 and homologous proteins provides valuable insights for functional characterization:
Comparison of selected UPF0295 family proteins:
| Protein | Species | Length | Sequence Similarity | Host Expression | UniProt ID |
|---|---|---|---|---|---|
| BA_0538/GBAA_0538/BAS0506 | Bacillus anthracis | 118 aa | Reference | E. coli | Q81YU3 |
| GTNG_0491 | Geobacillus thermodenitrificans | 117 aa | High similarity | E. coli | A4IKD1 |
| YgzB | Bacillus subtilis | ~120 aa | Moderate similarity | Multiple systems | P54556 |
| BPUM_0828 | Bacillus pumilus | ~118 aa | Moderate similarity | E. coli | A8FA88 |
To leverage this comparative approach:
Phylogenetic analysis: Construct evolutionary trees of UPF0295 proteins to identify conserved regions
Domain mapping: Identify functional domains conserved across homologs
Expression pattern comparison: Compare expression profiles under similar conditions
Complementation studies: Test functional interchangeability between homologs
Structural alignment: Compare predicted or determined structures to infer functional sites
This comparative approach can reveal evolutionarily conserved functions and species-specific adaptations, providing direction for targeted functional studies .
Designing protocols for membrane-associated proteins like UPF0295 requires specialized considerations:
Protocol design framework:
Sample preparation:
Use detergent screening to identify optimal solubilization conditions
Test multiple detergents (e.g., DDM, CHAPS, SDS) at varying concentrations
Consider native membrane mimetics (nanodiscs, liposomes) for functional assays
Purification strategy:
Implement gentle extraction procedures to preserve native conformation
Use two-phase partitioning for initial enrichment
Apply affinity chromatography with imidazole gradient elution for His-tagged UPF0295
Activity assays:
Design assays compatible with detergent presence
Include appropriate controls for detergent interference
Consider reconstitution into proteoliposomes for functional studies
Data analysis:
Account for detergent background in spectroscopic measurements
Apply appropriate normalization for membrane protein yields
Use specific statistical approaches for handling membrane protein variability
A comprehensive protocol must be sufficiently detailed to allow replication by other researchers while acknowledging potential limitations associated with membrane protein handling and stability .
Given the UPF designation and potential association with unfolded protein response (UPR) pathways, specialized approaches may be valuable:
UPR induction studies:
Expose cells to known UPR inducers (tunicamycin, thapsigargin)
Monitor UPF0295 expression changes using RT-qPCR and western blotting
Compare responses to established UPR markers
Multi-omics integration:
Combine transcriptomics, proteomics, and interactomics data
Apply pathway enrichment analysis to position UPF0295 within UPR networks
Use GSEA (Gene Set Enrichment Analysis) to identify associated pathways
UPR signature development:
Develop a UPR-related gene signature incorporating UPF0295
Validate signature across multiple stress conditions
Apply signature for predictive modeling of stress responses
Structure-function analysis:
Examine potential stress-responsive domains within UPF0295
Perform mutagenesis of conserved motifs to assess functional importance
Investigate potential redox-sensitive residues (note the cysteine residues in position 62 and 66)
These approaches can help position UPF0295 within the broader context of cellular stress response mechanisms and provide insights into its functional significance .